SEC 13F Intelligence

Tudor Investment Corp Et Al / ALDR1EUR

Tudor Investment Corp Et Al’s Alder Biopharmaceuticals Inc Position

Does Tudor Investment Corp Et Al own Alder Biopharmaceuticals Inc (ALDR1EUR)? Not currently — the last reported position was 1.12M shares worth $21M in Q3 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$21M
Q3 2019
Shares
1.12M
% of Portfolio
+0.72%
Quarters Held
3
position exited

Position History ALDR1EUR

Reported value by quarter
Q4 ’18: $186,000Q4 ’18Q2 ’19: $310,000Q2 ’19Q3 ’19: $21MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20191.12M$21M+0.72%
Q2 201926.3K$310,000+0.01%
Q4 201818.2K$186,0000.00%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tudor Investment Corp Et Al’s full portfolio or all institutional holders of ALDR1EUR.